Disparities in risk stratification guidance for patients taking immunosuppressive drugs during the COVID-19 pandemic - points to ponder

J R Coll Physicians Edinb. 2022 Jun;52(2):185-187. doi: 10.1177/14782715221103739. Epub 2022 Jun 17.

Authors

Arvind Nune¹, Pranav Ish², Karthikeyan P Iyengar¹, Arpit Mago³, Nauman Khan¹, Hem Raj Sapkota⁴

Affiliations

¹ Southport and Ormskirk Hospital NHS Trust, Southport, UK.
² Critical Care and Sleep Medicine, VMMC and Safdarjung Hospital, New Delhi, India.
³ Jawaharlal Nehru Medical College, Belgaum, India.
⁴ Royal Wolverhampton Hospital NHS Trust, Wolverhampton, UK.

PMID: 36147005
DOI: 10.1177/14782715221103739

No abstract available

Publication types

Letter

MeSH terms

COVID-19* / epidemiology
Humans
Immunosuppressive Agents / adverse effects
Pandemics
Risk Assessment
SARS-CoV-2

Substances

Immunosuppressive Agents